Cite
Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement.
MLA
Al-Adra, David P., et al. “Preexisting Melanoma and Hematological Malignancies, Prognosis, and Timing to Solid Organ Transplantation: A Consensus Expert Opinion Statement.” American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, vol. 21, no. 2, Feb. 2021, pp. 475–83. EBSCOhost, https://doi.org/10.1111/ajt.16324.
APA
Al-Adra, D. P., Hammel, L., Roberts, J., Woodle, E. S., Levine, D., Mandelbrot, D., Verna, E., Locke, J., D’Cunha, J., Farr, M., Sawinski, D., Agarwal, P. K., Plichta, J., Pruthi, S., Farr, D., Carvajal, R., Walker, J., Zwald, F., Habermann, T., … Watt, K. D. (2021). Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 21(2), 475–483. https://doi.org/10.1111/ajt.16324
Chicago
Al-Adra, David P, Laura Hammel, John Roberts, E Steve Woodle, Deborah Levine, Didier Mandelbrot, Elizabeth Verna, et al. 2021. “Preexisting Melanoma and Hematological Malignancies, Prognosis, and Timing to Solid Organ Transplantation: A Consensus Expert Opinion Statement.” American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 21 (2): 475–83. doi:10.1111/ajt.16324.